Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery

Cell Transplantation

Volumn 22, Issue 12, 2013, Pages 2291-2298

  Jiang, Yongjun ^a   Zhu, Wusheng ^a   Zhu, Juehua ^a   Wu, Li ^a   Xu, Gelin ^a   Liu, Xinfeng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Intra artery; Middle cerebral artery; Stem cells; Stroke

Indexed keywords

ADULT; ARTERY CATHETERIZATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE REPORT; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; DAILY LIFE ACTIVITY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INTRAARTERIAL UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANKIN SCALE; TREATMENT FAILURE;

ADIPOCYTES; ADULT; CATHETERIZATION, PERIPHERAL; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UMBILICAL CORD;

EID: 84890424686     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X658818     Document Type: Article

References (30)

1. Assmus, B.; Honold, J.; Schachinger, V.; Britten, M. B.; Fischer-Rasokat, U.; Lehmann, R.; Teupe, C.; Pistorius, K.; Martin, H.; Abolmaali, N. D.; Tonn, T.; Dimmeler, S.; Zeiher, A. M. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355:1222-1232; 2006.
2. Assmus, B.; Schachinger, V.; Teupe, C.; Britten, M.; Lehmann, R.; Dobert, N.; Grunwald, F.; Aicher, A.; Urbich, C.; Martin, H.; Hoelzer, D.; Dimmeler, S.; Zeiher, A. M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 106:3009-3017; 2002.
3. Bang, O. Y.; Lee, J. S.; Lee, P. H.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57:874-882; 2005.
4. Barbosa da Fonseca, L. M.; Battistella, V.; de Freitas, G. R.; Gutfilen, B.; Dos Santos Goldenberg, R. C.; Maiolino, A.; Wajnberg, E.; Rosado de Castro, P. H.; Mendez-Otero, R.; Andre, C. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120:539-541; 2009.
5. Brazzini, A.; Cantella, R.; De la Cruz, A.; Yupanqui, J.; Leon, C.; Jorquiera, T.; Brazzini, M.; Ortega, M.; Saenz, L. N. Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease. J. Vasc. Interv. Radiol. 21:443-451; 2010.
6. Cesselli, D.; Beltrami, A. P.; D'Aurizio, F.; Marcon, P.; Bergamin, N.; Toffoletto, B.; Pandolfi, M.; Puppato, E.; Marino, L.; Signore, S.; Livi, U.; Verardo, R.; Piazza, S.; Marchionni, L.; Fiorini, C.; Schneider, C.; Hosoda, T.; Rota, M.; Kajstura, J.; Anversa, P.; Beltrami, C. A.; Leri, A. Effects of age and heart failure on human cardiac stem cell function. Am. J. Pathol. 179:349-366; 2011.
7. Chen, J.; Li, Y.; Wang, L.; Zhang, Z.; Lu, D.; Lu, M.; Chopp, M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011; 2001.
8. Chopp, M.; Li, Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1:92-100; 2002.
9. Einstein, O.; Friedman-Levi, Y.; Grigoriadis, N.; Ben-Hur, T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J. Neurosci. 29:15694-15702; 2009.
10. Guillot, P. V.; Gotherstrom, C.; Chan, J.; Kurata, H.; Fisk, N. M. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654; 2007.
11. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Davalos, A.; Guidetti, D.; Larrue, V.; Lees, K. R.; Medeghri, Z.; Machnig, T.; Schneider, D.; von Kummer, R.; Wahlgren, N.; Toni, D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359:1317-1329; 2008.
12. Honmou, O.; Houkin, K.; Matsunaga, T.; Niitsu, Y.; Ishiai, S.; Onodera, R.; Waxman, S. G.; Kocsis, J. D. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134:1790-1807; 2011.
13. Jiang, W. J.; Yu, W.; Du, B.; Gao, F.; Cui, L. Y. Outcome of patients with >=70% symptomatic intracranial stenosis after wingspan stenting. Stroke 42:1971-1975; 2011.
14. Jiang, Y.; Zhu, J.; Xu, G.; Liu, X. Intranasal delivery of stem cells to the brain. Expert Opin. Drug Deliv. 8:623-632; 2011.
15. Lee, J. S.; Hong, J. M.; Moon, G. J.; Lee, P. H.; Ahn, Y. H.; Bang, O. Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099-1106; 2010.
16. Leung, T. W.; Yu, S. C.; Wong, K. S. Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial. Int. J. Stroke 6:312-314; 2011.
17. Liu, X. Beyond the time window of intravenous thrombolysis: Standing by or by stenting? Interv. Neurol. 1:3-15; 2012.
18. Liu, X.; Xu, G.; Wu, W.; Zhang, R.; Yin, Q.; Zhu, W. Subtypes and one-year survival of first-ever stroke in Chinese patients: The Nanjing Stroke Registry. Cerebrovasc. Dis. 22:130-136; 2006.
19. Lu, L. L.; Liu, Y. J.; Yang, S. G.; Zhao, Q. J.; Wang, X.; Gong, W.; Han, Z. B.; Xu, Z. S.; Lu, Y. X.; Liu, D.; Chen, Z. Z.; Han, Z. C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026; 2006.
20. Pendharkar, A. V.; Chua, J. Y.; Andres, R. H.; Wang, N.; Gaeta, X.; Wang, H.; De, A.; Choi, R.; Chen, S.; Rutt, B. K.; Gambhir, S. S.; Guzman, R. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 41:2064-2070; 2010.
21. Penn, M. S.; Ellis, S.; Gandhi, S.; Greenbaum, A.; Hodes, Z.; Mendelsohn, F. O.; Strasser, D.; Ting, A. E.; Sherman, W. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: Phase I clinical study. Circulation Res. 110:304-311; 2012.
22. Reeves, M. J.; Arora, S.; Broderick, J. P.; Frankel, M.; Heinrich, J. P.; Hickenbottom, S.; Karp, H.; LaBresh, K. A.; Malarcher, A.; Mensah, G.; Moomaw, C. J.; Schwamm, L.; Weiss, P. Acute stroke care in the US: Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36:1232-1240; 2005.
23. Roger, V. L.; Go, A. S.; Lloyd-Jones, D. M.; Adams, R. J.; Berry, J. D.; Brown, T. M.; Carnethon, M. R.; Dai, S.; de Simone, G.; Ford, E. S.; Fox, C. S.; Fullerton, H. J.; Gillespie, C.; Greenlund, K. J.; Hailpern, S. M.; Heit, J. A.; Ho, P. M.; Howard, V. J.; Kissela, B. M.; Kittner, S. J.; Lackland, D. T.; Lichtman, J. H.; Lisabeth, L. D.; Makuc, D. M.; Marcus, G. M.; Marelli, A.; Matchar, D. B.; McDermott, M. M.; Meigs, J. B.; Moy, C. S.; Mozaffarian, D.; Mussolino, M. E.; Nichol, G.; Paynter, N. P.; Rosamond, W. D.; Sorlie, P. D.; Stafford, R. S.; Turan, T. N.; Turner, M. B.; Wong, N. D.; Wylie-Rosett, J. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 123:e18-e209; 2011.
24. Savitz, S. I.; Dinsmore, J.; Wu, J.; Henderson, G. V.; Stieg, P.; Caplan, L. R. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc. Dis. 20:101-107; 2005.
25. Schachinger, V.; Erbs, S.; Elsasser, A.; Haberbosch, W.; Hambrecht, R.; Holschermann, H.; Yu, J.; Corti, R.; Mathey, D. G.; Hamm, C. W.; Suselbeck, T.; Assmus, B.; Tonn, T.; Dimmeler, S.; Zeiher, A. M. Intracoronary bone marrowderived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355:1210-1221; 2006.
26. Tipnis, S.; Viswanathan, C.; Majumdar, A. S. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: Role of B7-H1 and IDO. Immunol. Cell Biol. 88:795-806; 2010.
27. Tolar, J.; O'Shaughnessy, M. J.; Panoskaltsis-Mortari, A.; McElmurry, R. T.; Bell, S.; Riddle, M.; McIvor, R. S.; Yant, S. R.; Kay, M. A.; Krause, D.; Verfaillie, C. M.; Blazar, B. R. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood 107:4182-4188; 2006.
28. Troyer, D. L.; Weiss, M. L. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599; 2008.
29. Walczak, P.; Zhang, J.; Gilad, A. A.; Kedziorek, D. A.; Ruiz-Cabello, J.; Young, R. G.; Pittenger, M. F.; van Zijl, P. C.; Huang, J.; Bulte, J. W. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569-1574; 2008.
30. Wollert, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148; 2004.